Author

A. B. Green

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

J. E. Kirby· 2 shared K. A. Truelson· 2 shared K. E. Zulauf· 2 shared L. Chiaraviglio· 2 shared B. C. Miller· 1 shared E. W. Yu· 1 shared K. P. Smith· 1 shared M. Cui· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

J. E. Kirby

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Profiling the in vitro and in vivo activity of streptothricin-F against carbapenem-resistant Enterobacterales: a historic scaffold with a novel mechanism of action

K. P. Smith, Y.-S. Kang, A. B. Green, M. G. Dowgiallo, B. C. Miller, L. Chiaraviglio, K. A. Truelson, K. E. Zulauf, S. Rodriguez, R. Manetsch, J. E. Kirby

This paper evaluates the in vitro and in vivo activity of streptothricin-F against carbapenem-resistant Enterobacterales, identifying its potent activity and novel mechanism of action involving 16S rRNA helix 34.

bioRxiv · Jun 14, 2021 · PreprintMicrobiology

Amotosalen is a bacterial multidrug efflux pump substrate potentially affecting its pathogen inactivation activity

A. B. Green, K. E. Zulauf, K. A. Truelson, L. Chiaraviglio, M. Cui, Z. Zhang, M. P. Ware, W. A. Flegel, R. L. Haspel, E. W. Yu, J. E. Kirby

The paper investigates whether amotosalen, a psoralen used in pathogen inactivation, is a substrate for bacterial multidrug efflux pumps, finding it is pumped out by RND systems in E. coli and Acinetobacter baumannii, potentially reducing its inactivation efficacy against multidrug-resistant pathogens.

bioRxiv · Mar 15, 2021 · PreprintMicrobiology